WWMSC
TXMD icon

Wagner Wealth Management (South Carolina)’s TherapeuticsMD TXMD Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$8K Hold
23
– – 0.01% 446
2018
Q2 		$7K Buy
23
+19
+475% +$5.8K 0.01% 440
2018
Q1 		$1K Hold
4
– – ﹤0.01% 588
2017
Q4 		$1K Buy
+4
New +$1.11K ﹤0.01% 761

Other funds holding TXMD

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Wagner Wealth Management (South Carolina)'s TXMD Position: Q3 2018 in Review

Wagner Wealth Management (South Carolina) held its TherapeuticsMD (TXMD) position steady in Q3 2018 at 23 shares worth $8K. The position accounts for 0.01% of the portfolio, ranked #446.

Wagner Wealth Management (South Carolina) first reported a position in TXMD in Q4 2017 and has held it in 4 quarters since. 155 funds tracked by Wall St. Rank hold TXMD as of Q3 2018.

  • Wagner Wealth Management (South Carolina) held 23 shares of TherapeuticsMD worth $8K as of Q3 2018.
  • Wagner Wealth Management (South Carolina) left its TherapeuticsMD share count unchanged in Q3 2018.
  • TherapeuticsMD made up 0.01% of Wagner Wealth Management (South Carolina)'s portfolio in Q3 2018, its #446 holding.
  • Wagner Wealth Management (South Carolina) first reported a position in TherapeuticsMD in Q4 2017 and has held it in 4 quarters since.
  • 155 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2018.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q3 2018, filed 5 Nov 2018.